Cyfuse Biomedical K.K.
History
| Year | Detail |
|---|---|
| 2010 | Koji Kuchiishi and Koichi Nakayama founded Cyfuse Biomedical K.K.. |
| 2013 | The company has closed a $4.8 million Series A funding round, which will be used to forgo clinical development of its cartilage regeneration technology and further accelerate the deployment of its proprietary platform technology. |
| 2021 | The company has developed a Bio 3D Printer with a printing technology platform to create 3D tissues/organs, such as blood vessels, consisting solely of cells. |
| 2023 | PHC Corp., a wholly owned subsidiary of PHC Holdings Corp., and Cyfuse Biomedical K.K. entered a strategic alliance to develop products to advance regenerative and cellular medicines jointly. |
| 2024 | NSK Ltd. and Cyfuse Biomedical K.K. developed a new technology for practical application and commercialization of new cellular products in advanced growth areas such as regenerative medicine, cellular therapy, drug discovery, and healthcare. |
BCC Research Beacon 